Document:

exv10w1

 

EXHIBIT 10.1

MASTER SERVICES AGREEMENT

     THIS AGREEMENT, entered into and effective as of this 21 day of June 2007, (the “Effective
Date”), is by and between THE SPECTRANETICS CORPORATION (“Spectranetics”) and CRAIG WALKER. MD
(“Provider”).

WITNESSETH:

     WHEREAS, Spectranetics wishes to engage Provider to perform certain services (the “Services”)
and to create and deliver certain Work Product as defined below and Provider desires to accept
association with Spectranetics in such capacity and represents that it possesses the skills and
expertise required to perform the Services.

Work Product:

“Spectranetics” will pay $2500/day (minimum 6 hours) for any Spectranetics sponsored training
course at a maximum of 6 days per quarter.

Courses will include:

     Physician, observations

	 	o	 	A didactic session on laser safety and physics;
	 
	 	o	 	A didactic session on laser operation followed by a demonstration of the CVX-300;
	 
	 	o	 	A review of patient films demonstrating the lesions that meet the indications for use;
	 
	 	o	 	A review of cases demonstrating the proper CLiRpath technique in lesions that meet the indications for use.

     Spectranetics new hire training includes:

	 	o	 	Ancillary (Guide wires, sheaths, etc.)
	 
	 	o	 	Simulator use
	 
	 	o	 	Cines review

We will pay $2000/day (minimum 6 hours )for secondary sponsorship of any pre-approved courses,
including “hands-on” courses at a maximum of 5 days per quarter.

	 	o	 	A didactic session on laser safety and physics;
	 
	 	o	 	A didactic session on laser operation followed by a demonstration of the CVX-300;
	 
	 	o	 	A review of patient films demonstrating the lesions that meet the indications
for use
	 
	 	o	 	A minimum of 3 cases demonstrating the proper CLiRpath technique in lesions
that meet the indications for use required.
	 
	 	o	 	Spectranetics will also receive names and contact information for all
physicians trained during secondary sponsorship

1

 

Any additional unspecified courses will be paid at $2500/day (minimum 6 hours) with the same
FDA approved requirements. Additional courses must be pre-approved by Director of Sales, Mike
Ferguson or Director of Training, TBD.

     NOW, THEREFORE, in consideration of the mutual covenants and premises hereinabove
and hereinafter set forth, the parties hereby agree as follows:

1. SERVICES

     A. Provider will perform the Services in accordance with the highest professional
standards applicable to the performance of like services. Provider acknowledges that time is
of the essence in performance of the Services and failure of Provider to perform the Services in
the times specified will be grounds for termination of this Agreement by Spectranetics. To the
extent that the terms of the body of this Agreement and any Addendum conflict, the terms of
the Addendum will control.

     B. Spectranetics may periodically request written reports concerning Provider’s
progress, project status, cost data, and other matters pertaining to the Services, and
Provider will
promptly provide such reports to Spectranetics at no additional charge.

     C. In the event delay is caused by circumstances beyond the reasonable control of
Provider, without Provider’s fault or negligence, the time for performance of the Services
will be
extended by a reasonable period, not to exceed the number of days that such circumstances
exist.
The time for performance may be extended further upon written authorization by an authorized
representative of Spectranetics. In the event that such delay extends more than 30 calendar
days,
Spectranetics will have the option of canceling all or part of the Services.

2. COMPENSATION

     A. As full and complete consideration for the Services to be performed by
Provider, and for the rights granted in this Agreement, Spectranetics will pay Provider an
amount
upon quarterly statement received from “Provider” (the “Fees”). Unless otherwise expressly set
forth in any Addendum, no additional fees are payable by Spectranetics with respect to any
services performed by Provider in accordance with such Addendum. This Agreement will not
impact Spectranetics’ funding and support of the International Congress, and Spectranetics
will
continue annual funding of the International Congress as determined by Spectranetics.

     B. Spectranetics will reimburse Provider for reasonable pre-authorized travel and
lodging expenses incurred in connection with performance of the Services. Reimbursement will
be conditioned upon providing Spectranetics with itemized receipts and supporting
documentation submitted in accordance with Spectranetics’ instructions. All air travel will be
coach class unless approved in advance by an authorized representative of Spectranetics. Fees
are inclusive of all taxes, which are Provider’s responsibility.

2

 

3. CONFIDENTIALITY

     A. Provider represents and warrants to Spectranetics that the performance of the Services by
Provider will not violate any proprietary rights of third parties, including patents, copyrights or
trade secrets, and that Provider’s rendering of the Services to Spectranetics under this Agreement
will not violate any contractual obligations or confidential relationships that Provider may have
to or with any third party. Provider will defend, indemnify and hold Spectranetics, its parents,
subsidiaries and other affiliates, and the respective officers, directors, employees and agents of
each of them, harmless from and against any and all claims, suits, liabilities, losses, costs and
expenses (including attorneys’ and experts’ fees and court costs), arising from or incident to
Provider’s breach of these representations and warranties.

     B. Provider will hold in trust and confidence all of the information regarding Spectranetics’
business, the Services performed under this Agreement and the results thereof: (i) disclosed by
Spectranetics, its agents or employees to Provider; (ii) obtained from Spectranetics or otherwise
learned as a result of the Services performed for Spectranetics; or (iii) used as a basis for or
contained in any reports prepared by Provider for Spectranetics under this Agreement (all of which
will be called the “Confidential Information”). The existence and substance of this Agreement will
be considered part of the Confidential Information. Provider will not disclose all or any part of
the Confidential Information to any third party, make any press release regarding the existence of
this Agreement or make any commercial or other use of any of same without the prior written consent
of Spectranetics, which consent may be withheld for any or no reason.

     C. The restrictions in Section 3.B will not apply to any portion of the Confidential
Information that Provider clearly demonstrates falls within any of the following categories: (i)
Confidential Information that, as of the time of disclosure to Provider, was already known to
Provider without obligation of confidentiality, as demonstrated by appropriate documentary evidence
antedating the relationship between Provider and Spectranetics; (ii) Confidential Information
obtained after the Effective Date by Provider from a third party that is lawfully in possession of
such information and not in violation of any contractual or legal obligation to Spectranetics with
respect to such information; (iii) Confidential Information that is or becomes part of the public
domain through no fault of Provider or its employees; or (iv) Confidential Information that is
required to be disclosed by administrative or judicial action so long as Provider gives notice to
Spectranetics as soon as practicable after Provider becomes aware of such requirement.

     D. Provider will restrict access to all of the Confidential Information to only such limited
group of its employees and agents who: (i) require such information in connection with their
activities as contemplated by this Agreement; and (ii) have agreed in writing with Provider to
maintain the confidential nature of all proprietary information, including that of third parties,
received by them in the course of their employment.

     E. Upon termination of this Agreement, or earlier upon Spectranetics’ request, Provider will
deliver all items containing any Confidential Information to Spectranetics or make such other
disposition thereof as Spectranetics may direct.

3

 

     F. If requested by Spectranetics, Provider will maintain all or any portion of the written
materials relating to or containing the Confidential Information as may be designated by
Spectranetics in a restricted access area and plainly marked to indicate the secret and
confidential nature thereof and prevent unauthorized use or reproduction thereof.

     G. Disclosure of the Confidential Information to Provider hereunder will not
constitute any option, grant or license to Provider under any patent or other rights now
or hereinafter held by Spectranetics, its parents, subsidiaries or other affiliates.

     H. Provider hereby gives assurance to Spectranetics that it will not knowingly, unless it has
obtained prior written authorization from the U.S. Department of Commerce or is otherwise permitted
by the U.S. Department of Commerce Export Administration Regulations, export or otherwise disclose,
directly or indirectly, any technology received from Spectranetics, nor allow the direct product
thereof to be shipped, either directly or indirectly, to any destination that is proscribed under
Part 740 of the U.S. Department of Commerce Export Administration Regulations or to any national of
any one of those countries (“Prohibited Nationals”). Provider further agrees to notify
Spectranetics if it assigns any Prohibited National to perform Services under this Agreement.

4. OWNERSHIP OF WORK PRODUCT AND TECHNOLOGY

     A. Unless otherwise expressly agreed by the parties, all deliverables required by the Services
and all tangible and intangible property, work products, inventions and discoveries that are
conceived, developed, created or obtained by Provider specifically for Spectranetics in connection
with the performance of the Services (the “Work Product”), including all technical notes,
schematics, artwork, literature, methods, processes and photographs, will be considered “works made
for hire” and, therefore all right, title and interest therein, (including patents and copyrights)
will vest exclusively in Spectranetics. To the extent that all or any part of the Work Product does
not qualify as a “work made for hire” under applicable law, and except as otherwise expressly
agreed by the parties, Provider hereby irrevocably assigns to Spectranetics all right, title, and
interest (including patents and copyrights) in such Work Product. None of the Work Product will be
used by Provider on any other project or with any other client except with Spectranetics’ written
consent. If any part of the Work Product is the work of a subcontractor employed by Provider, then
Provider will require such subcontractor to execute a written assignment in form and substance
acceptable to Spectranetics so as to secure for Spectranetics exclusive ownership in the Work
Product. Provider will promptly thereafter deliver such assignment to Spectranetics. Additionally,
Provider will promptly prepare and deliver to Spectranetics any invention records or memoranda
requested by Spectranetics in connection with the Work Product. If any part of the materials
delivered to Spectranetics as part of the Services does not constitute Work Product (“Other
Materials”), Provider hereby grants to Spectranetics an unlimited, worldwide, non-exclusive,
perpetual, fully paid-up license to use, copy, modify and create derivative works from such Other
Materials.

     B. All products, engineering data, business plans and information, specifications, drawings,
or other Spectranetics property furnished by Spectranetics to Provider will remain the exclusive
property of Spectranetics. Such Spectranetics property will be used for no purpose

4

 

other than the performance of the Services. If requested by Spectranetics, Provider will sign
and deliver a written itemized receipt or loan agreement for all such property and will be
responsible for its safekeeping. Upon termination or expiration of this Agreement, such property
will be immediately returned to Spectranetics.

     C. Without further remuneration (except for its out-of-pocket expenses) and whether or not
this Agreement is in effect, Provider will, at Spectranetics’ request, execute and deliver to
Spectranetics any documents and give all reasonable assistance that may be essential or desirable
to secure to, assign, and vest in Spectranetics the sole and exclusive right, title, and interest
in and to the Work Product.

     D. Provider hereby irrevocably waives any and all “moral rights” that it may have in the Work
Product, or any part thereof, in connection with Spectranetics’ use thereof. To the extent such
waiver may be invalid or unenforceable, Provider will, without further remuneration (except for its
out-of-pocket expenses) and whether or not this Agreement is in effect, execute and deliver to
Spectranetics such waiver of Provider’s “moral rights” concerning the Work Product and
Spectranetics’ use thereof as may be requested by Spectranetics. Provider acknowledges that the
term “moral rights” as used herein includes the right of an author: to be known as the author of a
work; to prevent others from being named as the author of the work; to prevent others from falsely
attributing to the author the authorship of a work which he/she has not in fact created; to prevent
others from making deforming changes in the author’s work; to withdraw a published work from
distribution if it no longer represents the views of the author; and to prevent others from using
the work or the author’s name in such a way as to reflect negatively on his/her professional
standing.

5. NO EXCLUSIVITY

     Provider may engage in other business or research activities that do not affect its ability to
perform the Services or its other obligations under this Agreement.

6. REPRESENTATIONS AND WARRANTIES

     Each party hereby represents and warrants to the other that:

     A. It is duly organized, validly existing and in good standing in its state of organization or
incorporation and has all requisite power and authority to carry on its business as currently
conducted. It is duly qualified or licensed to do business and is in good standing under the laws
of each jurisdiction in which the nature of the activities conducted by it makes such qualification
necessary.

     B. It has all requisite power and authority to execute and deliver, to perform its obligations
under, and to consummate the transactions contemplated by, this Agreement, the Addenda, and all
other documents and instruments to be executed and delivered by it in connection with this
Agreement. The execution and delivery by it of, the performance by it of its obligations under, and
the consummation by it of the transactions contemplated by, this Agreement, the Addenda, and all
other documents and instruments to be executed and delivered

5

 

by it in connection with this Agreement have been duly authorized by all requisite corporate
action of it, and this Agreement is, and all other documents and instruments to be executed and
delivered by it in connection with this Agreement will be, the valid and binding obligations of it,
enforceable in accordance with their terms, except insofar as enforceability may be limited or
affected by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws now or
hereafter in effect affecting creditors’ rights generally or by principles governing the
availability of equitable remedies.

     C. The execution, delivery and performance by it of this Agreement, the Addenda, and all other
documents and instruments to be executed and delivered by it in connection with this Agreement will
not: (i) violate any provision of its organizational documents; (ii) require any consent, approval
or authorization of, or any filing with or notice to, any person; or (iii) (a) violate, conflict
with or constitute a breach of or default under any agreement (without regard to requirements of
notice, passage of time or elections of any person), (b) permit or result in the termination,
suspension, modification of, (c) result in the acceleration of (or give any person the right to
accelerate) its performance under, or (d) result in the creation or imposition of any encumbrance
under, any instrument or other agreement to which it is a party or by which it or any of its assets
is bound or affected, except for purposes of this clause (iii) such violations, conflicts,
breaches, defaults, terminations, suspensions, modifications and accelerations as would not,
individually or in the aggregate, have a material adverse effect on it or on the validity, binding
effect or enforceability of this Agreement.

7. INDEMNIFICATIONS

     A. Provider will defend, indemnify and hold Spectranetics, its parents, subsidiaries and other
affiliates, and the respective officers, directors, employees and agents of each of them (each, an
“Indemnitee”), harmless from and against all claims, suits, liabilities, losses, costs and expenses
(including attorneys’ and experts’ fees and court costs) arising from or incident to Provider’s
breach of this Agreement, Provider’s infringement of any third party’s intellectual property
rights, or misappropriation of third party confidential information, or personal or bodily injury
or property damage to the extent such injury and/or damage results from the negligence or willful
misconduct of Provider or its employees, agents or subcontractors; except, in each case, to the
extent that such losses result from the negligence or intentional misconduct of such Indemnitee.

     B. The obligations of Provider under this Section 8 to indemnify and hold any Indemnitee
harmless are subject to such Indemnitee (i) granting Provider control of the defense and settlement
of any such claim (provided that, in the event and to the extent that Provider fails or refuses to
reasonably defend such Indemnitee, then such Indemnitee will have the right to provide its own
defense at Provider’s expense), and (ii) reasonably assisting Provider in the defense of such
claim, provided that Provider reimburses such Indemnitee for out of pocket expenses. The failure by
any Indemnitee to provide prompt notice to Provider of a third party claim will not discharge any
of Provider’s obligations under this Section 8, except to the extent that Provider is materially
prejudiced by any delay or defect in the notice. Neither party will have any liability for, nor
obligation arising under, any settlement or compromise made without its prior written consent.

6

 

8. TERM, TERMINATION AND CANCELLATION

     A. This Agreement will commence on the Effective Date and will continue for a period of
one year, subject to a single renewal term for a period of one year as the parties may mutually
agree in writing (the ‘Term”). Notwithstanding the expiration or termination of this Agreement, if
and to the extent that Provider continues performance under any Addendum beyond the Term, this
Agreement will survive with respect to such performance.

     B. In addition to any other remedies to which it may be entitled at law or in equity, either
party may terminate this Agreement or any Addendum entered into under this Agreement, without
liability, upon written notice to the other if (i) the other makes a general assignment for the
benefit of creditors, or if an Order for Relief under title 11, United States Code, is entered
against the other or (ii) the other commits a material breach of its obligations under this
Agreement or such Addendum. However, in the case of any such breach which is capable of being
cured, neither party will terminate this Agreement or Addendum unless and until the other has
failed to cure such default within 30 days after it has been served with a written notice requiring
that such default be cured and stating its intention to terminate this Agreement or Addendum if
compliance with the notice is not met.

7

 

     C. Any other provision of this Agreement notwithstanding, Spectranetics will have the right,
within its sole discretion, to terminate the Services of Provider without further liability
hereunder for any reason whatsoever upon ten days prior written notice to Provider. In such event,
Spectranetics will be liable to Provider for the lesser of (i) all Fees paid and payable prior to
the effective date of termination or (ii) fees and expenses for the services actually performed
prior to the date of termination calculated at Provider’s standard rates plus costs
incurred by Provider as a direct result of such termination.

9. NOTICES

     All notices and other communications required or permitted to be given under this Agreement
will be in writing and will be delivered personally, or mailed by registered or certified mail,
return receipt requested, postage prepaid, by recognized overnight delivery service or by telecopy,
confirmed by mailing as described above, addressed as follows:

	 	 	 	 	 
	If to Spectranetics:

	 	The Spectranetics Corporation
	 	 
	 
	 	 	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	 	 	 
	 

	 	Attention:	 	 
	 
	 	 	 	 
	If to Provider:

	 	Craig Walker, MD	 	 
	 

	 	225 Dunn Street	 	 
	 

	 	Houma, LA 70360	 	 
	 

	 	Phone: 985-876-0300	 	 

Any notice so addressed and delivered personally will be deemed given upon receipt. Any notice so
addressed and mailed will be deemed given upon receipt, but in no event later than five days
following deposit in the United States mails in accordance with this Section 11, or one business
day following deposit with a recognized overnight delivery service. Either party may change its
address by giving the other notice thereof in the manner provided in this Section 11.

10. INDEPENDENT CONTRACTOR

     In performing the Services hereunder, Provider will act in the capacity of an independent
contractor and not as an employee or agent of Spectranetics. Provider will not represent itself as
an agent or legal representative of Spectranetics for any purpose whatsoever. Provider will be
solely responsible for the employment and remuneration of its employees and subcontractors and any
claims with respect thereto, and will be solely responsible for the withholding and payment of all
federal, state, and local income taxes as well as all FICA and FUTA taxes applicable to it, or such
employees and subcontractors. Provider acknowledges that as an independent contractor, neither it
nor any of its employees or subcontractors will be eligible for any Spectranetics employee
benefits, including vacation, medical, dental, or pension benefits. Provider will defend, indemnify
and hold Spectranetics, its parents, subsidiaries and other affiliates, and the respective
officers, directors, employees and agents of each of them, harmless from and against all claims,
suits, liabilities, losses, costs and expenses (including attorneys’ and experts’ fees and

8

 

court costs) made by any of Provider’s employees or independent contractors arising from or
incident to its failure to pay any such taxes or any allegation or claim by any such employee or
subcontractor including that they are or may be an employee or subcontractor of Spectranetics.

11. LIMITATION OF LIABILITY

     Except as specifically provided in this Agreement, in no event will either party be liable to
the other for any special, incidental or consequential damages or losses of any kind which may be
suffered by either of them with respect to the subject matter hereof. Such damages include
compensation, reimbursement or damages on account of present or prospective profits, expenditures,
investments or commitments, whether made in the establishment, development or maintenance of
business reputation or goodwill, or for any other reason whatsoever, including the claims of any
third party.

12. GENERAL

     A. Provider will comply with all statutes, ordinances, and regulations of all federal, state,
county and municipal or local governments, and of any and all of the departments and bureaus
thereof, applicable to the carrying on of its business and the performance of the Services.

     B. No right or interest in this Agreement will be assigned or subcontracted by Provider
without the prior written consent of Spectranetics, and no delegation of the performance of the
Services or other obligations owed by Provider to Spectranetics will be made without such consent
of Spectranetics, which consent may be withheld for any or no reason.

     C. Either party’s waiver of any breach or failure to enforce any of the terms and conditions
of this Agreement at any time will not in any way affect, limit or waive such party’s right
thereafter to enforce and compel strict compliance with every term and condition hereof.

     D. This Agreement will be deemed to have been made and executed in the State of Colorado and
any dispute arising hereunder will be resolved in accordance with the laws of Colorado, without
reference to its conflict of laws principles. In the event of any dispute related to this
Agreement, the prevailing party will be entitled to recover all its expenses related to such
dispute including reasonable attorneys fees and court costs.

     E. All the representations, warranties and indemnifications made by either party in this
Agreement and the obligations of Provider under Sections 4, 5, 8, 11, 12, 13, and the parties
respective obligations under Section 14 will survive the expiration or termination hereof.

     F. Except as specifically provided in this Agreement, the rights and remedies of the parties
set forth herein will be cumulative and in addition to any rights and remedies available to them at
law or in equity.

     G. This Agreement, including Exhibits and Addenda, constitutes the complete agreement between
the parties and supersedes all prior communications and agreements between them with respect to the
subject matter hereof and may not be modified or otherwise amended

9

 

except by a further writing executed by both parties hereto, which writing specifies that it is an
amendment hereto. Any term or provision of this Agreement which is invalid or unenforceable will be
ineffective to the extent of such invalidity or unenforceability without rendering invalid or
unenforceable the remaining rights of the party intended to be benefitted by such provision or any
other provisions of this Agreement.

     H. The captions of this Agreement are for convenience only and do not constitute a part of
this Agreement. Terms used with initial capital letters will have the meanings specified,
applicable to both singular and plural forms, for all purposes of this Agreement. The word
“include” and derivatives of that word are used in this Agreement in an illustrative sense rather
than limiting sense. This Agreement has been negotiated by Spectranetics and Provider and their
respective legal counsel, and legal or equitable principles that might require the construction of
this Agreement or any provision of this Agreement against the party drafting this Agreement will
not apply in any construction or interpretation of this Agreement.

     I. This Agreement may be executed in one or more counterparts, each of which shall
be deemed an original, and all of which taken together shall constitute one and the same
instrument.

[The remainder of this page has intentionally been left blank]

10

 

     IN WITNESS WHEREOF, the parties have by their duly authorized representatives have executed
this Agreement as of the Effective Date.

	 	 	 	 	 	 	 	 	 	 	 
	Provider:	 	 	 	Spectranetics:	 	 
	Craig Walker, MD	 	 	 	The Spectranetics Corporation	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	By:

	 	/s/ Craig Walker, MD
	 	 	 	By:	 	/s/ John G. Schulte	 	 
	 

	 	 
	 	 	 	 	 	 	 	 
	Name:

	 	Craig Walker, MD
	 	 	 	Name:	 	John G. Schulte	 	 
	Title:

	 	 	 	 	 	Title:	 	Chief Executive Officer	 	 	 	 

11

 

Addendum I

Speaker honorariums, will be reduced to $3000 per event to be paid out separately from the
quarterly consulting payment (speaking engagement must be pre-approved by Director of Marketing
Communications, Michelle Jackson).

Master Summits will be paid out separately at $10,000 for directing and $5000 for moderation.

12exv10w2

 

EXHIBIT 10.2

SECOND AMENDMENT TO

THE SPECTRANETICS CORPORATION

2006 INCENTIVE AWARD PLAN

     THIS SECOND AMENDMENT TO THE SPECTRANETICS CORPORATION 2006 INCENTIVE AWARD PLAN (this
“Second Amendment”), dated as of March 6, 2007, is made and adopted by The Spectranetics
Corporation (the “Company”), subject to approval by the stockholders of the Company.
Capitalized terms used but not otherwise defined herein shall have the respective meanings ascribed
to them in the Plan (as defined below).

RECITALS

     WHEREAS, the Company maintains The Spectranetics Corporation 2006 Incentive Award Plan, as
amended by the First Amendment, dated as of December 11, 2006 (the “Plan”);

     WHEREAS, the Company desires to amend the Plan as set forth herein; and

     WHEREAS, pursuant to Section 14.1 of the Plan, the Plan may be amended at any time and from
time to time with the approval of the Board of Directors of the Company, provided that approval by
the stockholders of the Company is required for any amendment to the Plan that increases the number
of shares available under the Plan (other than certain adjustments under the Plan).

     NOW, THEREFORE, BE IT RESOLVED, that, subject to approval by the stockholders of the Company,
the Plan be amended as follows:

     1. Section 3.1(a) of the Plan is hereby amended and restated in its entirety as follows:

               “(a) Subject to Article 11 and Section 3.1(b), the aggregate
number of shares
of Stock which may be issued or transferred pursuant to Awards under the Plan shall
be equal to the sum of (x) 700,000, (y) any shares of Stock which as of the
Effective Date are available for issuance under the 1997 Plan, and (z) any shares of
Stock subject to awards under the 1997 Plan which terminate, expire, lapse for any
reason or are settled in cash on or after the Effective Date; provided, however,
that such aggregate number of shares of Stock available for
issuance under the Plan shall be reduced by 1.50 shares for each share of Stock
delivered in settlement of any Full Value Award. In order that the applicable
regulations under the Code relating to Incentive Stock Options be satisfied, the
maximum number of shares of Stock that may be delivered under the Plan upon the
exercise of Incentive Stock Options shall be that number of shares specified in
Section 3.1(a)(x) above.”

     2. This Second Amendment shall be effective as of the date of approval by the stockholders of
the Company.

 

 

     3. Upon the approval by the stockholders of the Company, this Second Amendment shall be
incorporated in and form a part of the Plan.

     4. Except as set forth herein, the Plan shall remain in full force and effect.

          I hereby certify that the foregoing Second Amendment was duly adopted by the Board of
Directors of The Spectranetics Corporation on March 6, 2007.

* * * * *

          I hereby certify that the foregoing Second Amendment was approved by the stockholders of The
Spectranetics Corporation on June 19, 2007.

          Executed on this 19th day of June, 2007.

	 	 	 	 	 
	 	 	 
	 	By:  	/s/
Guy A. Childs
 	 
	 	 	Name:  	Guy A. Childs 	 
	 	 	Title:  	Secretary

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00125-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00125-of-00352.parquet"}]]